Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 24.21%575.12M | 23.54%163.14M | 31.83%151.15M | 20.06%170.42M | 21.60%90.41M | 130.39%463M | 74.57%132.06M | 154.82%114.66M | 99.18%141.94M | 720.44%74.35M |
Net income from continuing operations | 105.41%156.24M | 56.91%37.16M | 422.49%41.36M | 210.54%52.81M | -9.26%24.92M | 4,342.22%76.06M | 72.55%23.68M | -68.00%7.92M | 844.16%17M | 172.33%27.46M |
Operating gains losses | -50.00%7.05M | 3,817.29%13.59M | -64.80%4.52M | -248.90%-11.31M | 103.66%245K | 114.09%14.09M | 123.51%347K | 126.33%12.84M | 135.93%7.6M | 76.60%-6.69M |
Depreciation and amortization | 12.39%274.68M | 8.21%69.61M | 9.17%69.45M | 19.68%69.71M | 13.24%65.9M | 6.78%244.4M | 12.46%64.33M | 12.80%63.62M | 1.89%58.25M | 0.15%58.2M |
Deferred tax | 102.08%29.46M | 647.92%7.76M | -9.30%9.19M | 1,487.85%6.51M | -5.32%6M | 207.50%14.58M | 45.56%-1.42M | 620.02%10.13M | 90.85%-469K | 263.01%6.33M |
Other non cash items | 1.06%43.26M | -30.25%9.26M | 23.44%13.7M | -5.23%10.75M | 34.76%9.54M | -4.22%42.8M | -1.59%13.28M | -10.97%11.1M | -15.02%11.35M | 31.68%7.08M |
Change In working capital | -63.08%2.39M | -94.55%593K | 65.46%-3.85M | -3.03%29.46M | -0.72%-23.82M | 91.73%6.47M | 201.77%10.87M | -189.08%-11.14M | 29.04%30.38M | -319.47%-23.65M |
-Change in receivables | 112.19%2.71M | 133.80%1.08M | 122.87%1.48M | 66.83%-2.94M | 183.72%3.08M | -593.16%-22.21M | -369.60%-3.2M | -986.46%-6.48M | -796.76%-8.85M | -62.33%-3.68M |
-Change in inventory | -5.51%-7.52M | 74.55%-1.08M | -997.66%-4.69M | 25.96%-1.41M | 38.47%-355K | -51.76%-7.13M | -171.20%-4.23M | -6.48%-427K | -5.97%-1.9M | 39.07%-577K |
-Change in prepaid assets | -359.90%-20.71M | -429.93%-15.35M | -43.89%3.27M | 4.79%6.03M | -77.36%-14.66M | 293.04%7.97M | 3,446.04%4.65M | 33.47%5.83M | 35.13%5.76M | -27.99%-8.27M |
-Change in payables and accrued expense | 26.13%19.52M | 189.67%7.8M | 75.33%-1.41M | -17.90%29.38M | 5.97%-16.24M | 61.86%15.48M | 121.61%2.69M | -1,356.14%-5.73M | 56.67%35.79M | -1,253.76%-17.27M |
-Change in other current assets | -54.26%2.36M | 6,248.84%2.64M | -105.80%-294K | -89.80%5K | -93.90%5K | 548.24%5.16M | -127.22%-43K | 2,641.62%5.07M | -73.08%49K | -69.74%82K |
-Change in other current liabilities | 32.74%-2.54M | -403.70%-3.94M | 115.31%921K | -114.99%-119K | 307.48%599K | 8.72%-3.78M | 361.17%1.3M | -1,594.93%-6.02M | 149.84%794K | 108.68%147K |
-Change in other working capital | -21.96%8.57M | -2.75%9.43M | 7.71%-3.13M | -19.19%-1.5M | -36.55%3.76M | 262.52%10.98M | 115.80%9.7M | 61.66%-3.39M | -298.42%-1.26M | -12.10%5.92M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 24.21%575.12M | 23.54%163.14M | 31.83%151.15M | 20.06%170.42M | 21.60%90.41M | 130.39%463M | 74.57%132.06M | 154.82%114.66M | 99.18%141.94M | 720.44%74.35M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 49.01%-292.74M | 23.43%-130.64M | 94.57%-7.82M | 103.51%4.31M | -15.88%-158.59M | -135.75%-574.16M | 17.20%-170.61M | -458.14%-144.05M | -138.52%-122.65M | -420.68%-136.85M |
Capital expenditure reported | 24.85%-524.54M | 18.87%-136.32M | 54.84%-87.11M | 13.21%-144.31M | 8.20%-156.8M | -18.07%-697.99M | 7.29%-168.03M | -22.62%-192.89M | -17.18%-166.26M | -54.23%-170.81M |
Net PPE purchase and sale | 76.98%223M | ---293K | 54.90%74.29M | 228.45%149M | --0 | -64.19%126M | --0 | -75.92%47.96M | -52.04%45.36M | -58.98%32.68M |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | ---1.62M | ---- | ---- | ---- | ---- |
Net other investing changes | 1,695.83%8.79M | 717.79%5.97M | 468.56%4.99M | 77.93%-386K | -238.85%-1.79M | 86.92%-551K | 70.05%-967K | 152.36%878K | 57.48%-1.75M | -73.22%1.29M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 49.01%-292.74M | 23.43%-130.64M | 94.57%-7.82M | 103.51%4.31M | -15.88%-158.59M | -135.75%-574.16M | 17.20%-170.61M | -458.14%-144.05M | -138.52%-122.65M | -420.68%-136.85M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -346.11%-284.39M | -429.03%-141.64M | -331.04%-55.65M | -578.00%-162.08M | 3.66%74.98M | 214.02%115.55M | -11.25%43.05M | 162.00%24.09M | -4,697.12%-23.91M | 171.70%72.33M |
Net issuance payments of debt | 925.42%1.01B | 3,178.48%1.29B | -973.31%-196.19M | -404.14%-164.44M | 9.74%75.69M | 653.56%98.23M | 43.78%39.42M | 155.06%22.47M | -4,739.47%-32.62M | 154.55%68.97M |
Net common stock issuance | --123.96M | ---393K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | 49.36%28.75M | 166.75%7.74M | 1,014.00%18.06M | -78.10%2.47M | -86.00%484K | 412.62%19.25M | 413.63%2.9M | -18.79%1.62M | 843.89%11.27M | --3.46M |
Net other financing activities | -74,701.04%-1.44B | -197,799.73%-1.44B | -187,200.00%-1.87M | 95.89%-105K | -1,075.49%-1.2M | -109.65%-1.93M | -96.45%729K | 97.67%-1K | ---2.56M | 78.57%-102K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -346.11%-284.39M | -429.03%-141.64M | -331.04%-55.65M | -578.00%-162.08M | 3.66%74.98M | 214.02%115.55M | -11.25%43.05M | 162.00%24.09M | -4,697.12%-23.91M | 171.70%72.33M |
Net cash flow | ||||||||||
Beginning cash position | 17.47%29.97M | 438.71%137.05M | 59.95%49.36M | 3.93%36.72M | 17.47%29.97M | -19.37%25.51M | -76.24%25.44M | -49.65%30.86M | -14.01%35.34M | -19.37%25.51M |
Current changes in cash | -145.77%-2.01M | -2,528.50%-109.14M | 1,750.88%87.68M | 374.53%12.65M | -30.83%6.79M | 176.12%4.4M | 105.49%4.49M | -111.45%-5.31M | -122.63%-4.61M | 4.51%9.82M |
Effect of exchange rate changes | -224.59%-76K | -222.58%-38K | 116.04%17K | -114.62%-19K | -700.00%-36K | 117.28%61K | -91.07%31K | 82.03%-106K | 176.02%130K | -90.16%6K |
End cash Position | -6.97%27.88M | -6.97%27.88M | 438.71%137.05M | 59.95%49.36M | 3.93%36.72M | 17.47%29.97M | 17.47%29.97M | -76.24%25.44M | -49.65%30.86M | -14.01%35.34M |
Free cash flow | 121.53%50.58M | 174.56%26.82M | 181.86%64.04M | 207.39%26.12M | 31.17%-66.39M | 39.78%-234.99M | 65.93%-35.97M | 30.34%-78.23M | 65.57%-24.32M | 5.14%-96.47M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |